Nelson Capital Management, LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 118 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.14 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nelson Capital Management, LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$9,000
-18.2%
1,0000.0%0.00%
-33.3%
Q2 2019$11,000
+10.0%
1,0000.0%0.00%
+50.0%
Q1 2019$10,000
-9.1%
1,0000.0%0.00%
-33.3%
Q4 2018$11,000
-78.4%
1,000
-66.7%
0.00%
-75.0%
Q3 2018$51,000
+18.6%
3,0000.0%0.01%
+9.1%
Q2 2018$43,000
-24.6%
3,0000.0%0.01%
-26.7%
Q1 2018$57,000
+16.3%
3,0000.0%0.02%0.0%
Q4 2017$49,000
+8.9%
3,0000.0%0.02%0.0%
Q3 2017$45,000
+73.1%
3,0000.0%0.02%
+66.7%
Q2 2017$26,000
+62.5%
3,0000.0%0.01%
+80.0%
Q1 2017$16,000
+60.0%
3,000
-11.8%
0.01%
+66.7%
Q4 2016$10,000
-37.5%
3,4000.0%0.00%
-50.0%
Q3 2016$16,000
-20.0%
3,4000.0%0.01%
-25.0%
Q2 2016$20,000
-9.1%
3,400
-8.1%
0.01%0.0%
Q1 2016$22,000
-35.3%
3,7000.0%0.01%
-38.5%
Q4 2015$34,000
+61.9%
3,7000.0%0.01%
+62.5%
Q3 2015$21,000
-48.8%
3,7000.0%0.01%
-46.7%
Q2 2015$41,000
-29.3%
3,7000.0%0.02%
-28.6%
Q1 2015$58,000
+41.5%
3,700
+37.0%
0.02%
+40.0%
Q4 2014$41,000
+28.1%
2,700
-10.0%
0.02%
+25.0%
Q3 2014$32,000
-30.4%
3,0000.0%0.01%
-33.3%
Q2 2014$46,000
-14.8%
3,0000.0%0.02%
-25.0%
Q1 2014$54,000
+28.6%
3,0000.0%0.02%
+26.3%
Q4 2013$42,000
+35.5%
3,0000.0%0.02%
+26.7%
Q3 2013$31,000
+34.8%
3,0000.0%0.02%
+25.0%
Q2 2013$23,0003,0000.01%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Casdin Capital, LLC 1,400,000$12,320,0004.56%
EcoR1 Capital, LLC 2,568,119$22,599,0004.01%
FIC CAPITAL INC 960,338$8,451,0003.48%
Opaleye Management Inc. 580,000$5,104,0002.13%
DAFNA Capital Management LLC 225,000$1,980,0001.41%
RA Capital Management 1,250,000$11,000,0001.26%
Iguana Healthcare Management, LLC 215,000$1,892,0001.07%
Avoro Capital Advisors LLC 800,000$7,040,0000.89%
WASATCH ADVISORS LP 6,930,535$60,989,0000.85%
Cormorant Asset Management, LP 400,000$3,520,0000.58%
View complete list of SANGAMO THERAPEUTICS INC shareholders